Rocket Pharmaceuticals RCKT Cash Flow Statement (2014-2026)

NASDAQ RCKT
$3.87 +0.08 (+2.06%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Rocket Pharmaceuticals Quarterly Cash Flow Statement

Periods 50 quarters
Latest Jun 2026

Rocket Pharmaceuticals reported cash from operations of -$39.61M and free cash flow of -$39.62M for the quarter ended Jun 2026, up 19.1% year over year. This cash flow statement covers 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-49.37M-43.95M-42.41M-54.01M-57.60M-68.30M-60.75M-68.38M-64.18M-62.94M-64.82M-71.89M-68.57M-61.55M-63.52M-68.92M-52.01M-43.75M-48.82M123.21M
Depreciation and Depletion
0.80M0.77M1.00M1.10M-2.10M1.14M1.20M1.20M
Share-based Compensation
11.11M7.04M12.05M12.53M12.73M9.69M14.65M14.88M14.89M9.93M15.92M16.11M16.15M11.09M17.20M16.36M16.67M6.11M14.16M13.47M
Gains from Investment Securities
1.11M-2.88M-0.10M-0.00M
Asset Writedowns and Impairment
Cash from Operations
-27.41M-30.94M-39.22M-39.04M-43.86M-56.02M-57.56M-50.87M-57.15M-29.34M-56.86M-53.82M-52.10M-46.94M-55.79M-48.96M-50.42M-34.84M-45.39M-39.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-0.74M-0.80M-0.58M-0.40M-0.16M1.08M2.42M2.68M2.28M3.27M2.76M2.24M1.85M1.22M2.19M2.22M1.68M1.21M1.23M
Amortization of Deferred Charges
0.54M0.54M0.54M0.73M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M0.54M
Depreciation & Amortization (CF)Depreciation & Amortization
0.80M0.77M1.00M1.10M-2.10M1.14M1.20M1.20M
Change in Working Capital
Change in Account Payables
Change in Accured Expenses
6.14M-1.99M-0.49M3.04M4.64M2.48M-7.75M3.27M-1.13M15.76M-2.41M4.54M3.17M0.77M-5.26M8.12M-12.25M-0.97M-5.75M4.70M
Other Working Capital Changes
0.01M-0.29M3.94M-2.85M0.19M2.31M-0.87M-1.83M4.66M-4.66M1.15M-0.42M0.29M-0.35M0.47M-0.67M-0.74M-1.15M1.64M0.35M
Investing Activities
Capital Expenditures
3.88M1.97M1.96M2.90M0.50M3.00M3.02M4.12M4.66M4.65M2.04M1.93M1.59M0.31M0.36M0.05M-0.05M0.08M0.09M0.01M
Sales of Property, Plant and Equipment
Acquisitions
Change in Acquisitions & Divestments
53.56M38.30M81.98M81.69M58.41M50.82M62.34M108.25M66.40M72.34M101.02M96.13M99.83M86.48M82.26M84.50M123.00M91.00M66.25M51.00M
Cash from Investing Activities
-18.19M16.86M-62.99M78.79M23.46M-108.58M-36.72M31.21M48.25M-140.81M35.03M55.62M78.92M-37.87M-58.03M31.76M93.62M36.42M17.45M214.36M
Financing Activities
Other financing activities
16.45M-15.03M0.08M0.00M0.23M0.32M1.11M0.18M0.55M0.39M1.18M1.53M0.18M0.32M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Shares Issued and Repurchased
1.67M1.34M2.31M1.79M2.37M1.17M1.77M1.41M5.68M2.34M
Net Equity Issued and Repurchased
17.24M29.30M0.03M17.22M171.66M63.80M118.73M
Misc.
Cash from Financing Activities
26.64M1.14M0.08M17.25M29.53M108.44M18.34M0.18M189.49M0.39M1.18M1.53M0.18M182.85M0.21M-0.07M-0.00M0.15M
Change in Cash
-18.96M-12.94M-102.14M57.00M9.13M-56.17M-75.94M-19.48M180.59M-169.75M-20.64M3.33M26.99M98.04M-113.83M-16.99M43.13M1.58M-27.95M174.90M
Free Cash Flow
-31.29M-32.91M-41.18M-41.94M-44.36M-59.02M-60.58M-54.99M-61.80M-33.99M-58.89M-55.75M-53.69M-47.25M-56.15M-49.01M-50.37M-34.92M-45.49M-39.62M
Net Cash Flow
-18.96M-12.94M-102.14M57.00M9.13M-56.17M-75.94M-19.48M180.59M-169.75M-20.64M3.33M26.99M98.04M-113.83M-16.99M43.13M1.58M-27.95M174.90M